Clin Mol Hepatol.
2023 Jul;29(3):817-819. 10.3350/cmh.2023.0155.
Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
- 2Regenerative Medicine Research Center, Yonsei University Wonju College of Medicine, Wonju, Korea
- 3Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, Korea
- KMID: 2544000
- DOI: http://doi.org/10.3350/cmh.2023.0155
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
- Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
- Non-alcoholic fatty liver disease: Definition and subtypes
- Correspondence on Letter regarding “Risk factors in nonalcoholic fatty liver disease”
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
